开设账户
模拟账户
关于我们
即时报价及新闻
市场分析
财经日历
每日市场分析
交易平台
下载及介绍
使用教学
交易细则
各项细则
资金提存
推广和资讯
常见问题
联络我们
繁
简
EN
客户登入
开设账户
模拟账户
繁
简
EN
客户登入
开设账户
模拟账户
关于我们
上志国际介绍
上志国际优势
即时报价及新闻
即时报价
即时新闻
市场分析
财经日历
市场分析
交易平台
平台特点
平台教学
交易细则
各项细则
资金提存
推广和资讯
常见问题
联络我们
关于我们
交易细则
贵金属市场
交易平台
市场分析
推广和资讯
常见问题
联络我们
繁
简
EN
英伟达(NVDA.O):在CoRL大会上推出GR00T 2、Isaac Lab 3.0以及全新的开放式基准测试。
2026-11-09
英伟达(NVDA.O):在CoRL大会上推出GR00T 2、Isaac Lab 3.0以及全新的开放式基准测试。
返回
其他消息
2026-11-10
Skydance (SKYD.N) appointed Jeremy Latcham as president and chief creative officer of DC Films. James Gunn and Peter Safran will step down from their leadership roles.
Skydance (SKYD.N) appointed Jeremy Latcham as president and chief creative officer of DC Films. James Gunn and Peter Safran will step down from their leadership roles.
2026-11-09
Shanghai municipal Food and Drug Safety Committee issued its 15th Five-Year plan to ensure drug safety and promote high-quality pharmaceutical development, calling for targeted supervision of priority fields and products. It mandates establishment of accountability and risk‑sharing mechanisms for contract manufacturing and enforcement of quality‑and‑safety responsibilities defined in contract manufacturing agreements. The plan orders intensified on-site inspections at vaccine producers and full-
Shanghai municipal Food and Drug Safety Committee issued its 15th Five-Year plan to ensure drug safety and promote high-quality pharmaceutical development, calling for targeted supervision of priority fields and products. It mandates establishment of accountability and risk‑sharing mechanisms for contract manufacturing and enforcement of quality‑and‑safety responsibilities defined in contract manufacturing agreements. The plan orders intensified on-site inspections at vaccine producers and full-coverage targeted supervision for vaccines, blood products, advanced therapy drugs, sterile pharmaceuticals, special-category medicines and products with segmented production processes, with emphasis on data reliability, sterility assurance, deviation control and change management. It also tightens oversight of implantable and sterile medical devices and devices selected via centralized procurement, requires one-product/one-policy regulatory plans for innovative devices, and steps up checks on procurement of critical raw materials, finished‑product testing and release. Separately, Shanghai will launch a production quality-management upgrade for cosmetics manufacturers, prioritizing special-use cosmetics and products using new raw materials and strengthening raw‑material controls.
Chat with us
, powered by
LiveChat